Detalhe da pesquisa
1.
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.
Cell;
159(2): 318-32, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25303528
2.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation;
149(11): 825-838, 2024 03 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38059368
3.
Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity.
Physiol Rev;
98(4): 1911-1941, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30067159
4.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation;
147(22): 1670-1683, 2023 05 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37039015
5.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation;
145(3): 158-169, 2022 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34743554
6.
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Circulation;
146(13): 980-994, 2022 09 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35971840
7.
Genome-wide association study of circulating interleukin 6 levels identifies novel loci.
Hum Mol Genet;
30(5): 393-409, 2021 04 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33517400
8.
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Cardiovasc Diabetol;
22(1): 330, 2023 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38017482
9.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Diabetes Obes Metab;
24(8): 1578-1587, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35478433
10.
A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes.
Diabetes Obes Metab;
22(7): 1157-1166, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32115853
11.
Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases.
Int J Mol Sci;
21(2)2020 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31940797
12.
Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
Diabetologia;
61(2): 369-380, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29067487
13.
Increased adipose tissue aromatase activity improves insulin sensitivity and reduces adipose tissue inflammation in male mice.
Am J Physiol Endocrinol Metab;
313(4): E450-E462, 2017 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28655716
14.
Metabolic characteristics of individuals at a high risk of type 2 diabetes - a comparative cross-sectional study.
BMC Endocr Disord;
17(1): 40, 2017 Jul 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28705209
15.
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4.
Proc Natl Acad Sci U S A;
110(7): 2563-8, 2013 Feb 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23359679
16.
The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT.
J Biol Chem;
289(10): 6899-6907, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24451367
17.
Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
BMC Endocr Disord;
15: 51, 2015 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26407933
18.
IGFBP-7 and Outcomes in Heart Failure With Reduced Ejection Fraction: Findings From DAPA-HF.
JACC Heart Fail;
11(3): 291-304, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36592046
19.
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
J Am Coll Cardiol;
82(2): 142-157, 2023 07 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407113
20.
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
Arterioscler Thromb Vasc Biol;
31(1): 219-27, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20966399